Glenmark launches new pump packs for OTC adapalene gel in US
In short
Glenmark launched new 15 g and 45 g pump packs for its over-the-counter adapalene gel in the US. The report says the target market is US OTC dermatology, and a similar Differin gel segment had $45.8 million in yearly sales.
This matters because it could help Glenmark compete in a market with existing demand. The reporting does not say expected sales or the launch date.
What the reporting says
Glenmark launched new 15 g and 45 g pump packs for its OTC adapalene gel in the US market, according to publisher-supplied reporting. The summary says the packs target the US OTC dermatology market, where the comparable Differin gel segment recorded $45.8 million in annual sales. The report does not state launch timing beyond the announcement or say how much sales Glenmark expects.
Why it matters
Glenmark’s new 15 g and 45 g pump packs are aimed at the US OTC dermatology market, according to the summary. The reported $45.8 million annual sales figure for the comparable Differin gel segment suggests a meaningful category opportunity, but the source does not provide Glenmark’s expected revenue or market share. Investors may view this as a product expansion move.